121 related articles for article (PubMed ID: 36123176)
21. CD47 expression and CD163
Imam R; Chang Q; Black M; Yu C; Cao W
BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
[TBL] [Abstract][Full Text] [Related]
22. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
[TBL] [Abstract][Full Text] [Related]
23. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.
Wong J; Fulp WJ; Strosberg JR; Kvols LK; Centeno BA; Hodul PJ
Am J Surg; 2014 Nov; 208(5):775-780. PubMed ID: 24997491
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
25. Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.
Park E; Ha HK; Chung MK
Int Urol Nephrol; 2011 Dec; 43(4):1059-65. PubMed ID: 21626133
[TBL] [Abstract][Full Text] [Related]
26. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma.
Wang S; Chen X; Fan J; Lu L
Ann Surg Oncol; 2016 Nov; 23(12):4101-4109. PubMed ID: 27436201
[TBL] [Abstract][Full Text] [Related]
28. Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
Chopde A; Gupta A; Chaudhari V; Parghane R; Basu S; Ostwal V; Ramaswamy A; Puranik A; Shrikhande SV; Bhandare MS
Langenbecks Arch Surg; 2023 May; 408(1):204. PubMed ID: 37212896
[TBL] [Abstract][Full Text] [Related]
29. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: a retrospective study.
Okubo Y; Kasajima R; Suzuki M; Miyagi Y; Motohashi O; Shiozawa M; Yoshioka E; Washimi K; Kawachi K; Kameda Y; Yokose T
BMC Cancer; 2017 Nov; 17(1):769. PubMed ID: 29145818
[TBL] [Abstract][Full Text] [Related]
31. Venous Invasion in Pancreatic Neuroendocrine Tumors Is Independently Associated With Disease-free Survival and Overall Survival.
Shi C; Chen W; Davis R; Morse MA
Am J Surg Pathol; 2023 Jun; 47(6):678-685. PubMed ID: 37017316
[TBL] [Abstract][Full Text] [Related]
32. Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors.
Li Y; Fan G; Yu F; Tian C; Tan H
Neuroendocrinology; 2021; 111(12):1231-1237. PubMed ID: 33370727
[TBL] [Abstract][Full Text] [Related]
33. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
[TBL] [Abstract][Full Text] [Related]
34. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
35. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors.
Arima K; Okabe H; Hashimoto D; Chikamoto A; Nitta H; Higashi T; Kaida T; Yamamura K; Kitano Y; Komohara Y; Yamashita YI; Beppu T; Takeya M; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):734-739. PubMed ID: 28285371
[TBL] [Abstract][Full Text] [Related]
37. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution.
Estrella JS; Li L; Rashid A; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Am J Surg Pathol; 2014 Feb; 38(2):147-57. PubMed ID: 24418850
[TBL] [Abstract][Full Text] [Related]
38. Challenging the Current Risk Factors of Appendiceal Neuroendocrine Neoplasms: Can They Accurately Predict Local Lymph Nodal Invasion? Results from a Large Case Series.
Galanopoulos M; McFadyen R; Drami I; Naik R; Evans N; Luong TV; Watkins J; Caplin M; Toumpanakis C
Neuroendocrinology; 2019; 109(2):179-186. PubMed ID: 31060039
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of venous invasion in stage IB node-negative gastric cancer.
Araki I; Hosoda K; Yamashita K; Katada N; Sakuramoto S; Moriya H; Mieno H; Ema A; Kikuchi S; Mikami T; Watanabe M
Gastric Cancer; 2015 Apr; 18(2):297-305. PubMed ID: 24687437
[TBL] [Abstract][Full Text] [Related]
40. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.
Primavesi F; Klieser E; Cardini B; Marsoner K; Fröschl U; Thalhammer S; Fischer I; Hauer A; Urbas R; Kiesslich T; Neureiter D; Zitt M; Klug R; Wundsam H; Sellner F; Karner J; Függer R; Cakar-Beck F; Kornprat P; Öfner D; Stättner S;
Eur J Surg Oncol; 2019 Feb; 45(2):198-206. PubMed ID: 30262324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
